Investigational Weight Loss Medication Study (Phase 3 Clinical Trial)

Now Enrolling in Dallas, Gardena, New Orleans, Panorama City, Santa Ana, and Westlake

Now Enrolling

About this research study

Obesity is associated with an increased risk of developing hypertension, cardiovascular (CV) disease, obstructive sleep apnea, and many other medical conditions. Losing weight with lifestyle changes can be difficult to maintain long term, and weight-loss surgeries can present with major risks.

Velocity is now seeking participants for an investigational weight loss medication study in conjunction with lifestyle changes.

Eligible participants...

  • Must be age 18 to 75
  • Must NOT have been diagnosed with T1D or T2D
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Dallas, Texas • Velocity Clinical Research

7777 Forest Lane, Suite C-685, Dallas, TX 75230
Phone: (682) 348-1169

Gardena, California • Velocity Clinical Research

1141 W. Redondo Beach Blvd., Suite 308, Gardena, CA 90247
Phone: (424) 551-7316

New Orleans, Louisiana • Velocity Clinical Research

3308 Tulane Ave., Suite 600, New Orleans, LA 70119
Phone: (504) 304-7197

Van Nuys, California • Velocity Clinical Research

15211 Vanowen Street, Suite 100, Van Nuys, CA 91405
Phone: (818) 532-6880

Santa Ana, California • Velocity Clinical Research

2621 South Bristol Street #303, Santa Ana, CA 92704
Phone: (714) 599-8711

Los Angeles (Westlake), California • Velocity Clinical Research

1127 Wilshire Blvd, Suite 805, Los Angeles, CA 90017
Phone: (213) 483-1800

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy